返回
Leishmaniasis
DOI:10.1016/S0140-6736(18)31204-2.png)
摘要
En 中文
Leishmaniasis is a poverty-related disease with two main clinical forms: visceral leishmaniasis and cutaneous leishmaniasis. An estimated 0.7-1 million new cases of leishmaniasis per year are reported from nearly 100 endemic countries. The number of reported visceral leishmaniasis cases has decreased substantially in the past decade as a result of better access to diagnosis and treatment and more intense vector control within an elimination initiative in Asia, although natural cycles in transmission intensity might play a role. In east Africa however, the case numbers of this fatal disease continue to be sustained. Increased conflict in endemic areas of cutaneous leishmaniasis and forced displacement has resulted in a surge in these endemic areas as well as clinics across the world. WHO lists leishmaniasis as one of the neglected tropical diseases for which the development of new treatments is a priority. Major evidence gaps remain, and new tools are needed before leishmaniasis can be definitively controlled.
Keyword:
LIPOSOMAL AMPHOTERICIN-B
HUMAN-IMMUNODEFICIENCY-VIRUS
AZAR DERMAL LEISHMANIASIS
HIV-INFECTED PATIENTS
INTRALESIONAL MEGLUMINE ANTIMONIATE
AMERICAN CUTANEOUS LEISHMANIASIS
DIRECT AGGLUTINATION-TEST
TIME PCR ASSAY
VISCERAL LEISHMANIASIS
KALA-AZAR
AI总结
对已上传原文的论文进行重点信息的提取,主要内容包括:简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
88.5
论文数:
5.4W
被引数:
34.8W
机构
引用论文
Evidence for three adult fast myosin heavy chain isoforms in type II skeletal muscle fibers in pigs.
Calcium-Sensitive Cross-Bridge Transitions in Mammalian Fast and Slow Skeletal Muscle Fibers
Science
IF0

